Breast Cancer
Brain Metastases Analysis Points to Distinct Tumor Immune Microenvironments, Potential Treatments
Researchers conducted an immunogenomic analysis of brain metastases from individuals with primary lung or breast cancer.
Immune Signatures Outperform TILs for HER2-Positive Breast Cancer Prognoses
Immune-related gene expression signatures tracked more closely with treatment response and outcomes than tumor-infiltrating lymphocytes in early-stage HER2-positive breast cancer.
Gene Expression Score IDs Breast Cancer Patients Responsive to Histone Deacetylase 6 Inhibitor
Premium
The gene activity signature could serve as a predictive biomarker for HDAC6 inhibitor response among metastatic breast cancer patients.
Guardant Health, Susan G. Komen Partner to Evaluate MRD Test in Breast Cancer
The test is designed to detect circulating tumor DNA in early-stage cancer patients after surgery to help oncologists identify those with residual or recurring disease.
Everything Genetic, Berkshire and Surrey Pathology Services Jointly Launch Cancer NGS Service in UK
BSPS will provide cancer sequencing services using two cancer gene panels currently under development at Everything Genetic to customers across the UK.